2004•Zhongguo aizheng zazhiRequires access

Study on the expression of cyclooxygenase-2 protein in gastric carcinoma and correlation with P-glycoprotein

Jun Liu

Open publisher page 1 citations

Abstract

Purpose:To investigate the cyclooxygenase-2(COX-2) expression in gastric carcinoma and investigate the effects of COX-2 expression on P-glycoprotein. Methods:The expression of COX-2 and P-glycoprotein was examined by immunohistochemical staining in 48 cases of gastric carcinoma and 10 cases of normal gastric tissues. Results:There was no positive signal of COX-2 detected in normal gastric tissue. The positive expression rate of COX-2 was 60.4 %(29/48) in gastric carcinoma. The expression of COX-2 was correlated with TNM stage and lymph node metastasis (P0.05). We also found that P-glycoprotein expression rate in COX-2 positive expression group was 82.8 %(24/29), and 63.2%(12/19) of P-glycoprotein was not expressed in COX-2 negative expression group. The over-expressions of COX-2 was significantly correlated with P-glycoprotein, The correlation coefficient was r=0.470 (P0.01). Conclusions:COX-2 expression is involved in the carcinogenesis and malignant progression of gastric carcinoma, also COX-2 might take part in mediation of multidrug-resistance (MDR) in gastric carcinoma through interference in the P-glycoprote in expressions.

About this research paper

What this paper is about

Purpose:To investigate the cyclooxygenase-2(COX-2) expression in gastric carcinoma and investigate the effects of COX-2 expression on P-glycoprotein. Methods:The expression of COX-2 and P-glycoprotein was examined by immunohistochemical staining in 48 cases of gastric carcinoma and 10 cases of normal gastric tissues. Results:There was no positive signal of COX-2 detected in normal gastric tissue. The positive expression rate of COX-2 was 60.4 %(29/48) in gastric carcinoma. The expression of COX-2 was correlated with TNM stage and lymph node metastasis (P0.05). We also found that P-glycoprotein expression rate in COX-2 positive expression group was 82.8 %(24/29), and 63.2%(12/19) of P-glycoprotein was not expressed in COX-2 negative expression group. The over-expressions of COX-2 was significantly correlated with P-glycoprotein, The correlation coefficient was r=0.470 (P0.01). Conclusions:COX-2 expression is involved in the carcinogenesis and malignant progression of gastric carcinoma, also COX-2 might take part in mediation of multidrug-resistance (MDR) in gastric carcinoma through interference in the P-glycoprote in expressions.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Purpose:To investigate the cyclooxygenase-2(COX-2) expression in gastric carcinoma and investigate the effects of COX-2 expression on P-glycoprotein. Methods:The expression of COX-2 and P-glycoprotein was examined by immunohistochemical staining in 48 cases of gastric carcinoma and 10 cases of normal gastric tissues. Results:There was no positive signal of COX-2 detected in normal gastric tissue. The positive expression rate of COX-2 was 60.4 %(29/48) in gastric carcinoma. The expression of COX-2 was correlated with TNM stage and lymph node metastasis (P0.05). We also found that P-glycoprotein expression rate in COX-2 positive expression group was 82.8 %(24/29), and 63.2%(12/19) of P-glycoprotein was not expressed in COX-2 negative expression group. The over-expressions of COX-2 was significantly correlated with P-glycoprotein, The correlation coefficient was r=0.470 (P0.01). Conclusions:COX-2 expression is involved in the carcinogenesis and malignant progression of gastric carcinoma, also COX-2 might take part in mediation of multidrug-resistance (MDR) in gastric carcinoma through interference in the P-glycoprote in expressions.

Key concepts: Immunohistochemistry, Cyclooxygenase, P-glycoprotein, Carcinogenesis, Medicine, Stage (stratigraphy), Gastric carcinoma, Carcinoma

Related papers

Back to paper searchBrowse research topicsOriginal source
Study on the expression of cyclooxygenase-2 protein in gastric carcinoma and correlation with P-glycoprotein — Research Paper | ScholarLens